Aayush Wellness Limited (BOM:539528)
25.55
+0.46 (1.83%)
At close: Jul 10, 2026
Aayush Wellness Revenue
In the fiscal year ending March 31, 2026, Aayush Wellness had annual revenue of 1.55B INR with 111.98% growth. Aayush Wellness had revenue of 484.07M in the quarter ending March 31, 2026, with 116.56% growth.
Revenue
1.55B
Revenue Growth
+111.98%
P/S Ratio
0.80
Revenue / Employee
222.12M
Employees
7
Market Cap
1.24B
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.55B | 821.36M | 111.98% |
| Mar 31, 2025 | 733.46M | 727.43M | 12,063.47% |
| Mar 31, 2024 | 6.03M | -74.99M | -92.56% |
| Mar 31, 2023 | 81.02M | -93.56M | -53.59% |
| Mar 31, 2022 | 174.58M | -1.34B | -88.48% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.34B |
| Bal Pharma | 3.12B |
| Parnax Lab | 2.49B |
| Lactose (India) | 1.63B |
| Godavari Drugs | 1.07B |
| Concord Drugs | 787.37M |
| Mercury Laboratories | 759.37M |
| Speciality Medicines | 752.85M |